Skip to main content
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia
Published Web Location
http://europepmc.org/articles/PMC4068832?pdf=renderNo data is associated with this publication.
Abstract
Acute myeloid leukemia (AML) is a clinically heterogeneous disease, with a 5-year disease-free survival (DFS) ranging from under 10% to over 70% for distinct groups of patients. At our institution, cytarabine, etoposide and busulfan are used in first or se
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.